WeedMD’s Color Cannabis Vaporizers Make Strong Entry in Ontario

WeedMD’s Color Cannabis Vaporizers Make Strong Entry in Ontario

First week of shipment to Ontario Cannabis Store (OCS) sends strain-specific Color Cannabis 510 vapes to “OCS Top 5” status as availability expands to retailers and other provinces
TORONTO, Oct. 26, 2020 (GLOBE NEWSWIRE) — WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis is pleased to announce it has commenced shipping its Color Cannabis-branded 510 vaporizer cartridges (“vapes”) to Canada’s largest retail distributor, the Ontario Cannabis Store (“OCS”). Color vapes landed in the “Top 5” status when compared to over 30 available vape brands during its first week of availability, according to OCS-provided data.WeedMD’s legacy cultivars Pedro Sweet Sativa and Ghost Train Haze, are produced at the Company’s state-of-the-art extraction hub utilizing WeedMD’s own terpene-rich biomass. Additional strain-specific offerings, such as Mango Haze and Black Sugar Rose, are scheduled to follow soon.“The initial success of our Color vapes in Canada’s largest retail market is a significant milestone for our team and reflects the increased brand recognition and strong consumer interest in our quality-derived products,” said Stephen Ng, Chief Commercial Officer. “Our terpene-rich products under Color and Saturday are garnering national appeal as we prepare to launch a broader portfolio of products from our best-in-class cultivation and production platform.”In addition to Color vapes, WeedMD recently launched a new cultivar ‘Black Sugar Rose’ coming this fall, as well as strain-specific pre-roll products, nitrogen-infused packaging and a brand partnership with PAX Labs Inc. for its PAX® ERA® and ERA PRO™line of strain-specific vapes. The Company also announced it is the exclusive Canadian supplier and distributor of acclaimed U.S.-based wellness house Mary’s Medicinals, with topicals production slated to commence at WeedMD’s extraction hub in Aylmer, ON later this year.
  
Information about upcoming corporate events can be found here. Access WeedMD’s latest investor deck here
About WeedMD Inc.WeedMD Inc. is the publicly-traded parent company of WeedMD RX Inc. and Starseed Medicinal Inc., licence holders producing and distributing cannabis products for both the medical and adult-use markets. The Company owns and operates a 158-acre state-of-the-art greenhouse, outdoor and processing facility located in Strathroy, Ontario as well as a fully-licensed 26,000 sq. ft. Aylmer, Ontario processing facility, specializing in cannabis extraction. With the addition of Starseed, a medical-centric operator based in Bowmanville, Ontario, WeedMD has expanded its multi-channeled distribution strategy. Starseed’s industry-first, exclusive partnership with LiUNA, the largest construction union in Canada, along with other employers and union groups complements WeedMD’s direct sales to medical patients. The Company maintains strategic relationships in the seniors’ market and supply agreements with Shoppers Drug Mart as well as seven provincial distribution agencies where adult-use brands Color Cannabis and Saturday are sold.Follow WeedMD, Color Cannabis & Starseed: LinkedIn: https://ca.linkedin.com/company/weedmd
Twitter: https://twitter.com/WeedMD
Instagram: https://www.instagram.com/weedmd/
Instagram: https://www.instagram.com/callitcolor/
&
Instagram: https://www.instagram.com/starseedca/
For further information, please contact:For Investor Enquiries:
Valter Pinto
Managing Director
KCSA Strategic Communications
1-212-896-1254
weedmd@kcsa.com
For Media Enquiries:
Marianella delaBarrera
VP, Communications & Corporate Affairs
416-897-6644
marianella@weedmd.com
Forward Looking Information This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation which are based upon WeedMD’s current internal expectations, estimates, projections, assumptions and beliefs and views of future events. Forward-looking information can be identified by the use of forward-looking terminology such as “expect”, “likely”, “may”, “will”, “should”, “intend”, “anticipate”, “potential”, “proposed”, “estimate” and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions “may”, “would” or “will” happen, or by discussions of strategy.The forward-looking information in this news release is based upon the expectations, estimates, projections, assumptions and views of future events which management believes to be reasonable in the circumstances. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of fact. Forward-looking information in this news release include, but are not limited to, statements with respect to internal expectations, expectations with respect to actual production volumes, expectations for future growing capacity and the completion of any capital project or expansions. Forward-looking information necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally; the ability of WeedMD to implement its business strategies; the COVID-19 pandemic; competition; crop failure; and other risks.Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, WeedMD does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for WeedMD to predict all such factors. When considering this forward-looking information, readers should keep in mind the risk factors and other cautionary statements in WeedMD’s disclosure documents filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com. The risk factors and other factors noted in the disclosure documents could cause actual events or results to differ materially from those described in any forward-looking information.NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASEA photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/58dd036b-2317-41bf-897a-eba64e5575b9

CBJ Newsmakers

Recommended
Knight Signs New Exclusive AmBisome® Agreement with Gilead in BrazilBombardier Announces Closing Date, Amended Terms for Sale of Aerostructures Business to Spirit AeroSystems Holding, Inc.